Atish Patel
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 27
- Drug Transport and Resistance Mechanisms 26
-
- Cancer therapeutics and mechanisms 10
- Co-authors
- Zhe‐Sheng Chen (31 shared papers)Liuya Wei (2 shared papers)Guofang Chen (1 shared paper)Huizhong Xu (1 shared paper)Rishil J. Kathawala (19 shared papers)Kamlesh Sodani (15 shared papers)Nagaraju Anreddy (10 shared papers)Tanaji T. Talele (10 shared papers)
- Journals
- Biochemical Pharmacology (4 papers)Oncotarget (4 papers)Molecular Cancer Therapeutics (2 papers)Cancer Letters (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaMalaysia
In The Last Decade
Atish Patel
32 papers receiving 1.9k citations
Atish Patel's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 866
- Biomaterials 190
- Materials Chemistry 533
- Molecular Biology 740
- Infectious Diseases 198
Countries citing papers authored by Atish Patel
This map shows the geographic impact of Atish Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atish Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atish Patel more than expected).
Fields of papers citing papers by Atish Patel
This network shows the impact of papers produced by Atish Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atish Patel. The network helps show where Atish Patel may publish in the future.
Co-authors
The 25 scholars most cited alongside Atish Patel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Silver nanoparticles: synthesis, properties, and therapeutic applications Hit paper breakdown → | 2014 | 757 |
| 2 | 2011 | 239 | |
| 3 | 2012 | 101 | |
| 4 | 2014 | 90 | |
| 5 | 2012 | 53 | |
| 6 | 2011 | 50 | |
| 7 | 2014 | 48 | |
| 8 | 2014 | 45 | |
| 9 | 2014 | 41 | |
| 10 | 2013 | 41 | |
| 11 | 2014 | 39 | |
| 12 | 2013 | 38 | |
| 13 | 2014 | 34 | |
| 14 | 2014 | 32 | |
| 15 | 2015 | 31 | |
| 16 | 2017 | 31 | |
| 17 | 2014 | 30 | |
| 18 | 2014 | 29 | |
| 19 | 2014 | 26 | |
| 20 | 2014 | 26 |
About Atish Patel
Atish Patel is a scholar working on Oncology, Molecular Biology, Surgery, Pediatrics, Perinatology and Child Health and Hematology, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (26 papers), Cancer therapeutics and mechanisms (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Pharmacological Effects and Toxicity Studies (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), HIV/AIDS drug development and treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Oncology (866 citations), Biomaterials (190 citations), Materials Chemistry (533 citations), Molecular Biology (740 citations) and Infectious Diseases (198 citations). Atish Patel has collaborated with scholars based in United States, China and Malaysia. Frequent co-authors include Zhe‐Sheng Chen, Liuya Wei, Guofang Chen, Huizhong Xu, Rishil J. Kathawala, Kamlesh Sodani, Nagaraju Anreddy, Tanaji T. Talele, Liwu Fu and Amit K. Tiwari. Their work appears in journals such as Biochemical Pharmacology, Oncotarget, Molecular Cancer Therapeutics, Cancer Letters and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.